CN108569980A - The method of purification of impurity in a kind of iprovalicarb active compound - Google Patents

The method of purification of impurity in a kind of iprovalicarb active compound Download PDF

Info

Publication number
CN108569980A
CN108569980A CN201810636797.2A CN201810636797A CN108569980A CN 108569980 A CN108569980 A CN 108569980A CN 201810636797 A CN201810636797 A CN 201810636797A CN 108569980 A CN108569980 A CN 108569980A
Authority
CN
China
Prior art keywords
impurity
iprovalicarb
active compound
purification
filtrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810636797.2A
Other languages
Chinese (zh)
Inventor
尚伟
陈朗
章莉玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang De Heng Testing Technology Co Ltd
Original Assignee
Zhejiang De Heng Testing Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang De Heng Testing Technology Co Ltd filed Critical Zhejiang De Heng Testing Technology Co Ltd
Priority to CN201810636797.2A priority Critical patent/CN108569980A/en
Publication of CN108569980A publication Critical patent/CN108569980A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification

Abstract

The invention discloses a kind of methods of purification of impurity in iprovalicarb active compound, include the following steps:1) it is dissolved by heating after being mixed with a certain amount of methanol as raw material using iprovalicarb crude product;2) wait for that solution cooled and filtered takes first-time filtrate;3) first-time filtrate is gradually dropped after solid is precipitated in water, filters to take secondary filtrate;4) it is eluant, eluent secondary filtrate decompression to be evaporated off after solvent with ethyl acetate and petroleum ether, it is carried out removing solvent under reduced pressure after separation obtains target impurity solution with column chromatography silica gel, obtains 3 methyl N of target impurity 2 (isopropoxyamino) (1 p tolylethyl) butanamide.Easy to operate, low manufacture cost of the invention, can get sample of the purity 90% or more.

Description

The method of purification of impurity in a kind of iprovalicarb active compound
Technical field
The present invention relates to fungicide technical field, more particularly to the method for purification of impurity in a kind of iprovalicarb active compound.
Background technology
Iprovalicarb be amino-acid ester analog derivative, be one kind aim at prevention downy mildew and specifically developed wide-spectrum bactericide, Its lasting period is long, especially good to the downy mildew preventive effect on the crops such as cucumber, grape.
According to China's laws and regulations requirement, pesticide must carry out registration experiment, and pesticide original medicine must then carry out full proximate analysis Experiment needs the impurity to content higher than 0.1% to carry out qualitative and quantitative analysis, during this measurement analysis, it is necessary to It to be compareed using standard substance to provide structure and content, is essential.
2- (isopropoxyamino) -3-methyl-N- (1-p-tolylethyl) butanamide is iprovalicarb active compound In process of production, the impurity isopropanol contained in iprovalicarb raw materials for production isopropyl chloroformate and valine and 1- (4- first Phenyl) ethamine reaction generate impurity, content of the impurity in iprovalicarb active compound be usually above 0.1%, need use standard Substance carries out qualitative and quantitative analysis to it.But there has been no No. CAS at present for the substance, also standard items not on sale on the market It is commercially available.
Invention content
In view of the deficiencies of the prior art, the technical problem to be solved is that provide a kind of convenient, of low cost, ring by the present invention The method of purification of impurity in the iprovalicarb active compound of guarantor, so as to the substance of quick obtaining to high-purity, and then for examining detection.
The present invention is so that above-mentioned technical problem is addressed by the following technical programs.
The method of purification of impurity, includes the following steps in a kind of iprovalicarb active compound:1) using iprovalicarb crude product as raw material and one It is dissolved by heating after quantitative methanol mixing;2) wait for that solution cooled and filtered takes first-time filtrate;3) first-time filtrate is gradually dropped in water After solid is precipitated, secondary filtrate is filtered to take;4) it is elution secondary filtrate decompression to be evaporated off after solvent with ethyl acetate and petroleum ether Agent is carried out removing solvent under reduced pressure after separation obtains target impurity solution with column chromatography silica gel, obtains target impurity
2-(isopropoxyamino)-3-methyl-N-(1-p-tolylethyl)butanamide。
Preferably, the volume proportion of ethyl acetate and petroleum ether is 1 in eluant, eluent:10~1:20.
Preferably, target impurity purity is more than 90%.
Beneficial effects of the present invention:Easy to operate, low manufacture cost of the invention, can get
2- (isopropoxyamino) -3-methyl-N- (1-p-tolylethyl) butanamide purity 90% with On sample.
Specific implementation mode
In order to facilitate the present invention is understood, the preferred embodiment of invention now given below is detailed to present invention progress to retouch It states.
Embodiment 1
About 53g iprovalicarb crude products are added in 250mL beakers, about 160mL methanol is added, heating is allowed to be dissolved to clarification, It waits for that solution is cooled to room temperature, filters the solution and take first-time filtrate, first-time filtrate is gradually dropped in 400mL water, solid is precipitated, mistake It is eluant, eluent that the secondary filtrate decompression of leaching, which is evaporated off after solvent with ethyl acetate and petroleum ether, is detached, is washed with column chromatography silica gel Ethyl acetate in de- agent:Petroleum ether is 1:20 (v/v) remove solvent under reduced pressure after obtaining target impurity solution, obtain purity and exist 90% or more target impurity
2-(isopropoxyamino)-3-methyl-N-(1-p-tolylethyl)butanamide。

Claims (3)

1. the method for purification of impurity in a kind of iprovalicarb active compound, it is characterized in that:Include the following steps:1) it is original with iprovalicarb crude product Material dissolves by heating after being mixed with a certain amount of methanol;2) wait for that solution cooled and filtered takes first-time filtrate;3) first-time filtrate is gradually dripped Enter after solid is precipitated in water, filters to take secondary filtrate;4) ethyl acetate and petroleum ether are used after solvent being evaporated off in secondary filtrate decompression For eluant, eluent, is carried out removing solvent under reduced pressure after separation obtains target impurity solution with column chromatography silica gel, obtain target impurity 2- (isopropoxyamino)-3-methyl-N-(1-p-tolylethyl)butanamide。
2. the method for purification of impurity in iprovalicarb active compound according to claim 1, it is characterized in that:Ethyl acetate in eluant, eluent Volume proportion with petroleum ether is 1:10~1:20.
3. the method for purification of impurity in iprovalicarb active compound according to claim 1, it is characterized in that:Target impurity purity is more than 90%.
CN201810636797.2A 2018-06-20 2018-06-20 The method of purification of impurity in a kind of iprovalicarb active compound Pending CN108569980A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810636797.2A CN108569980A (en) 2018-06-20 2018-06-20 The method of purification of impurity in a kind of iprovalicarb active compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810636797.2A CN108569980A (en) 2018-06-20 2018-06-20 The method of purification of impurity in a kind of iprovalicarb active compound

Publications (1)

Publication Number Publication Date
CN108569980A true CN108569980A (en) 2018-09-25

Family

ID=63573384

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810636797.2A Pending CN108569980A (en) 2018-06-20 2018-06-20 The method of purification of impurity in a kind of iprovalicarb active compound

Country Status (1)

Country Link
CN (1) CN108569980A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453531A (en) * 1990-08-25 1995-09-26 Bayer Aktiengesellschaft Substituted valinamide derivatives
CN1098250C (en) * 1996-08-02 2003-01-08 拜尔公司 Process for preparing substituted valine amide derivatives
CN1193020C (en) * 2000-04-03 2005-03-16 伊哈拉化学工业株式会社 Process for preparing amic acid esters

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453531A (en) * 1990-08-25 1995-09-26 Bayer Aktiengesellschaft Substituted valinamide derivatives
CN1098250C (en) * 1996-08-02 2003-01-08 拜尔公司 Process for preparing substituted valine amide derivatives
CN1193020C (en) * 2000-04-03 2005-03-16 伊哈拉化学工业株式会社 Process for preparing amic acid esters

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MAN SUN等: "Design, synthesis, and fungicidal activities of imino diacid analogs of valine amide fungicides", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
卢平,张钰萍: "杀菌剂异丙菌胺原药的反相高效液相色谱分析方法", 《农药科学与管理》 *

Similar Documents

Publication Publication Date Title
JP3386796B2 (en) Quality determination method for plants of the genus Salicaceae and / or extracts thereof
Porter Multiple-paper chromatogram
CN101863809A (en) Method for purifying doxercalciferol
CN108569980A (en) The method of purification of impurity in a kind of iprovalicarb active compound
CN106928217A (en) A kind of Analogue of moxifloxacin and preparation method thereof, purposes
CN111141850B (en) Liquid phase detection separation method for related substances of acetaminophen bulk drug
CN109251161B (en) Preparation method of 2-tryptophan bisulfite
Zhou et al. Preparative separation of punicalin from waste water of hydrolysed pomegranate husk by macroporous resin and preparative high-performance liquid chromatography
CN113583077B (en) Process for preparing sterols
CN107976506B (en) Detection method of obeticholic acid related substances
CN104945300B (en) Purification method for I-type atorvastatin calcium
CN105061179B (en) Dryopteris fragrans phloroglucinol derivative and its isomer method for separating and preparing and application
CN106290695B (en) Method for separating and measuring desonide and related impurities
CN110256189A (en) The technique of lycopene is extracted from tomato peel
CN104483400B (en) Method for separating and measuring oxiracetam and intermediate thereof by liquid chromatography
JPH0675472B2 (en) Method for producing high-purity egg yolk lecithin
CN113336755A (en) Method for separating and purifying trigonelline, chlorogenic acid and caffeine
JP2002294274A (en) High purity of glycosyl ceramide and method for producing the same
Lv et al. Enantiomeric resolution of new triazole compounds by high‐performance liquid chromatography
CN110668922A (en) Refining method of musk medulla
CN107305199B (en) Method for separating and measuring two components and related substances in compound nasal spray of azelastine hydrochloride and fluticasone propionate
Folkers et al. Erythrina Alkaloids. XII. Chromatographic Analyses of Erysodine, Erysovine and “Erysocine” and Technique for Preparative Isolation1
CN108610436A (en) A kind of method of separation of glasses acid sodium and heterozygosis chondroitin sulfate
CN107827904A (en) A kind of purification process of qinghaosu
CN115236231B (en) Separation method of Fmoc-NH-PEGn-propionic acid homolog

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180925

WD01 Invention patent application deemed withdrawn after publication